eucerin white therapy 相關
廣告Local 24/7 Crisis Phone Line 614-276-CARE. Find Help Immediately. Speak with a Licensed Clinician.
搜尋結果
AIA One Absolute – Cancer & Serious Infectious Disease Protection. A first-in-market cancer protection that determines your claims based on the severity of your medical journey, while adding support for existing and unknown serious infectious diseases. Benefit term Up to age 85. Issue age 15 days to age 65. Brochure.
Overview. Featured benefits. Compare similar products. Get in touch. Cancer Care Essence. Specific cancer cover with life protection, giving you support through critical times. Benefit term Up to age 80. Issue age of Insured Age 18 to 60. Brochure. Standard premium schedule. Policy contract. Covered illnesses explained. Get in touch.
Nurturing your mental, physical and nutritional health - The path to holistic balance. With wellness services exclusively dedicated to the esteemed AIA Club Alta 1 members, AIA Alta Wellness Haven powered by Humansa is Hong Kong insurance's first 2 integrated and one-stop wellness realm where science blends seamlessly with Eastern and Western ...
Combining protection with value-added services, the plan covers different medical expenses for covered cancer from prevention and prediction† to diagnosis, treatment and recovery, while providing personalised support. With Cancer Guardian Pearl 3, you can plan a happy future with confidence and peace of mind. •.
AIA has introduced a first-in-market cancer protection that determines your claims based on the severity of your medical journey for cancer and carcinoma-in-situ via a scoring table, while adding support for existing and unknown serious infectious diseases. Enjoy a permanent 20% premium discount above a specified Sum Assured.
市場首個專為「三高」人士而設的全方位保障計劃，提供貼心的醫療、危疾、人壽全方位保障. 自願醫保的產品提供者. 公司名稱: 友邦保險（國際）有限公司. 公司註冊編號: 00013. 註冊生效日期: 2019年2月28日. 不適用於新申請. AIA自願醫保尊裕計劃. AIA自願醫保 ...
Clinical trial drugs bring new hopes to cancer treatment but are more costly and are not covered by other individual medical plans3. A 3-year targeted therapy for breast cancer and lung cancer is around HKD1.13 million and HKD1 million respectively4.
